Phase 2a Study Evaluating a Chemokine-Modulatory Regimen in Patients With Colorectal Cancer Metastatic to the Liver
Phase of Trial: Phase II
Latest Information Update: 01 Feb 2019
At a glance
- Drugs Celecoxib (Primary) ; Interferon alpha-2b (Primary) ; Rintatolimod (Primary)
- Indications Carcinoma; Colorectal cancer
- Focus Therapeutic Use
- 12 Dec 2018 Planned primary completion date changed from 1 Dec 2018 to 1 Feb 2019.
- 15 Nov 2018 According to a Hemispherx Biopharma media release, four of the twelve planned patients have been enrolled in this trial.
- 12 Nov 2018 Planned End Date changed from 1 Nov 2019 to 1 Dec 2019.